Alkem Labs Gains As U.S. FDA Conducts Audit At Daman Plant – Shares of the Mumbai-based drug maker rose as much as 2.1 percent t0 Rs 2,150 as U.S. drug regulator conducts a surprise audit at its largest facility in Daman, two people aware of the development told BloombergQuint requesting anonymity.
Read More: Stocks To Watch: Amtek, Dalmia Bharat, Fortis, JSPL, TCS
The U. S. Food and Drug Administration officials began inspecting the site yesterday, which is expected to go on for another four to five days, the two people quoted aboved said. The officials are mainly auditing the quality control practices and production line of the Mumbai-based drug maker.
